The trigemino-vascular system and migraine

Pathol Biol (Paris). 1992 Apr;40(4):313-7.

Abstract

Neurogenic inflammation has been proposed as a possible pathogenetic mechanism for migraine and cluster headache. Antidromic stimulation of trigeminal fibers causes plasma protein extravasation, mast cell activation and degranulation, vacuolation and increase in endothelial vesicle number within post capillary venules in rat dura mater. The antimigraine drugs sumatriptan and dihydroergotamine block the development of plasma extravasation and ultrastructural changes, as well as plasma calcitonin gene-related peptide (CGRP) increase in the superior sagittal sinus following electrical trigeminal ganglion stimulation. Sumatriptan and dihydroergotamine bind with high affinity to the 5-HT1D/1B receptors, thus suggesting that their neurogenic antiinflammatory activity is mediated by activation of 5-HT autoreceptors present on sensory fibers innervating blood vessels in dura mater.

Publication types

  • Review

MeSH terms

  • Blood Proteins / metabolism
  • Calcitonin Gene-Related Peptide / metabolism
  • Cerebrovascular Disorders / complications*
  • Cerebrovascular Disorders / metabolism
  • Cranial Nerve Diseases / complications
  • Dihydroergotamine / pharmacology
  • Dihydroergotamine / therapeutic use
  • Dura Mater / drug effects
  • Dura Mater / metabolism
  • Humans
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Migraine Disorders / drug therapy
  • Migraine Disorders / etiology
  • Migraine Disorders / metabolism
  • Migraine Disorders / physiopathology*
  • Receptors, Serotonin / drug effects
  • Substance P / metabolism
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use
  • Sumatriptan
  • Trigeminal Nerve / drug effects
  • Trigeminal Nerve / physiopathology*
  • Vasoconstrictor Agents / pharmacology
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Blood Proteins
  • Indoles
  • Receptors, Serotonin
  • Sulfonamides
  • Vasoconstrictor Agents
  • Substance P
  • Dihydroergotamine
  • Sumatriptan
  • Calcitonin Gene-Related Peptide